Bandyopadhyay, Sourav
11 papers on CoChatORCID 0000-0003-3120-923X
Most cited papers
- Verified
Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell
HIV Research and TreatmentHIV/AIDS drug development and treatment
Cited by 960
- Verified
Rewiring of Genetic Networks in Response to DNA Damage
Bandyopadhyay, S., Mehta, M., Kuo, D., Sung, M.-K., Chuang, R., Jaehnig, E. J., Bodenmiller, B., Licon, K., Copeland, W., Shales, M., et al. (2010) · Science
Fungal and yeast genetics researchDNA Repair Mechanisms
Cited by 447
- Verified
Conservation and Rewiring of Functional Modules Revealed by an Epistasis Map in Fission Yeast
Roguev, A., Bandyopadhyay, S., Zofall, M., Zhang, K., Fischer, T., Collins, S. R., Qu, H., Shales, M., Park, H.-O., Hayles, J., et al. (2008) · Science
Bioinformatics and Genomic NetworksFungal and yeast genetics research
Cited by 352
- Verified
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer
Shah, K. N., Bhatt, R., Rotow, J., Rohrberg, J., Olivas, V., Wang, V. E., Hemmati, G., Martins, M. M., Maynard, A., Kuhn, J., et al. (2019) · Nature Medicine
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 286
- Verified
An expanded universe of cancer targets
Hahn, W. C., Bader, J. S., Braun, T. P., Califano, A., Clemons, P. A., Druker, B. J., Ewald, A. J., Fu, H., Jagu, S., Kemp, C. J., et al. (2021) · Cell
Cancer Genomics and DiagnosticsChromatin Remodeling and Cancer
Cited by 213
- Verified
Integrating physical and genetic maps: from genomes to interaction networks
Beyer, A., Bandyopadhyay, S., & Ideker, T. (2007) · Nature Reviews Genetics
Bioinformatics and Genomic NetworksGene Regulatory Network Analysis
Cited by 207
- Verified
NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer
Blakely, C. M., Pazarentzos, E., Olivas, V., Asthana, S., Yan, J. J., Tan, I., Hrustanovic, G., Chan, E., Lin, L., Neel, D. S., et al. (2015) · Cell Reports
Lung Cancer Treatments and MutationsNF-κB Signaling Pathways
Cited by 204
- Verified
Functional Maps of Protein Complexes from Quantitative Genetic Interaction Data
Bandyopadhyay, S., Kelley, R., Krogan, N. J., & Ideker, T. (2008) · PLoS Computational Biology
Bioinformatics and Genomic NetworksGene Regulatory Network Analysis
Cited by 141
- Verified
Epithelial-to-Mesenchymal Transition Rewires the Molecular Path to PI3K-Dependent Proliferation
Salt, M. B., Bandyopadhyay, S., & McCormick, F. (2014) · Cancer Discovery
Cancer Cells and MetastasisPI3K/AKT/mTOR signaling in cancer
Cited by 124
- Verified
Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins
Martinko, A. J., Truillet, C., Julien, O., Diaz, J. E., Horlbeck, M. A., Whiteley, G., Blonder, J., Weissman, J. S., Bandyopadhyay, S., Evans, M. J., et al. (2018) · eLife
Protein Kinase Regulation and GTPase SignalingProtein Degradation and Inhibitors
Cited by 91
- Verified
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer
Donnella, H. J., Webber, J. T., Levin, R. S., Camarda, R., Momcilovic, O., Bayani, N., Shah, K. N., Korkola, J. E., Shokat, K. M., Goga, A., et al. (2018) · Nature Chemical Biology
PI3K/AKT/mTOR signaling in cancerAdvanced Breast Cancer Therapies
Cited by 90
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free